Viewing Study NCT01814943



Ignite Creation Date: 2024-05-06 @ 1:28 AM
Last Modification Date: 2024-10-26 @ 11:04 AM
Study NCT ID: NCT01814943
Status: COMPLETED
Last Update Posted: 2013-06-18
First Post: 2013-03-18

Brief Title: The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
Sponsor: AstraZeneca
Organization: AstraZeneca

Study Overview

Official Title: The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
Status: COMPLETED
Status Verified Date: 2013-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is conducted in a cohort of low dose aspirin ASA users previously ascertained The aims of the post hoc analyses are

To estimate the incidence of uncomplicated peptic ulcer UPU in a cohort of low-dose ASA for secondary prevention of vascular disease and the relative risk of UPU associated with use and discontinuation of use of low dose ASA

To estimate the effect of proton pump inhibitors PPI on the occurrence of UPU among users of low-dose ASA for secondary prevention of vascular disease To evaluate the effect of other risk factors on the occurrence of UPU among users of low-dose ASA for secondary prevention of vascular disease
Detailed Description: The risk of uncomplicated peptic ulcer in a cohort of secondary prevention aspirin users

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None